Cell Marker Predictors in Barrett's Esophagus
Sponsor
The Guthrie Clinic (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03316053
Collaborator
(none)
25
1
60.5
0.4
Study Details
Study Description
Brief Summary
The purpose of this study is to analyze biopsied tissue samples for changes in cells and genes involved in Barrett's Esophagus.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Patients with a history of Barrett's esophagus who are scheduled for a routine endoscopy will have an additional biopsy taken for genetic testing.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
25 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Cell Marker Predictors in Barrett's Esophagus
Actual Study Start Date
:
Nov 15, 2017
Anticipated Primary Completion Date
:
Dec 1, 2021
Anticipated Study Completion Date
:
Dec 1, 2022
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Tissue Sample for genetic testing Biopsy sample |
Other: Tissue sample for genetic testing
Tissue sample to be obtained during routine endoscopy
|
Outcome Measures
Primary Outcome Measures
- Cell Markers [through study completion, an average of 1 year]
Identify genes involved in Barrett's Esophagus
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- History of Barrett's esophagus; scheduled for routine upper endoscopy
Exclusion Criteria:
-
Under 18 years of age
-
Unable to consent on own behalf
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | The Guthrie Clinic | Sayre | Pennsylvania | United States | 18840 |
Sponsors and Collaborators
- The Guthrie Clinic
Investigators
- Principal Investigator: John Ford, MD, The Guthrie Clinic
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
The Guthrie Clinic
ClinicalTrials.gov Identifier:
NCT03316053
Other Study ID Numbers:
- 1708-43
First Posted:
Oct 20, 2017
Last Update Posted:
Feb 3, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: